Episode

Why almost 80% of my patients are quietly quitting Ozempic

Podcast
Jason Fung
Published
Sep 27, 2026
Duration seconds
1138
Processing state
not_requested
Canonical source
https://traffic.megaphone.fm/HD7980919538.mp3
Audio
https://traffic.megaphone.fm/HD7980919538.mp3
JSON
/v1/public/podcasts/jason-fung-8014235/episodes/why-almost-80-of-my-patients-are-quietly-quitting-ozempic
Markdown
/podcast/jason-fung-8014235/why-almost-80-of-my-patients-are-quietly-quitting-ozempic.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/jason-fung-8014235/episodes/why-almost-80-of-my-patients-are-quietly-quitting-ozempic/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/jason-fung-8014235/why-almost-80-of-my-patients-are-quietly-quitting-ozempic.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Are weight-loss drugs like Ozempic, Wegovy, and Tirzepatide truly miracle cures? In this in-depth video, Dr. Jason Fung breaks past the media hype to examine real-world data, including cohort studies from JAMA and Blue Cross Blue Shield (BHI), revealing a side of modern weight-loss treatments that few are talking about.While clinical trials paint a glowing picture, real-world statistics tell a different story: a massive percentage of patients—ranging from 60% to nearly 80%—stop taking these medications within one to two years. But why are millions of people walking away from a drug that promised them results?Dr. Jason Fung uncovers the three major hidden problems with modern obesity drugs that explain why patients ultimately throw in the towel. From the shocking drop-off in long-term persistence and the subtle erosion of life’s greatest daily pleasures to the frustrating reality that these drugs simply stop working over time, this video exposes the true cost of GLP-1 therapy.📌 In This Video, You Will Discover:● The Real-World Data: Why up to 80% of patients discontinue Ozempic and similar GLP-1 agonists despite having insurance coverage.● The Quality of Life Dilemma: How suppressing appetite often strips away the joy of eating, socializing, and celebrating milestones.● The Plateau Effect: Why weight loss quickly halts after 6 to 9 months as the body adapts and energy expenditure decreases.● The Long-Term Trap: Why simply telling patients to "take it forever" ignores human nature, clinical economics, and patient well-being.Whether you are considering these medications, currently on a weight-loss journey, or looking for sustainable, natural alternatives to health and fasting, this analysis provides the crucial insights you need.🔔 Subscribe to the channel for more science…